Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosome abnormalities in leukemia.

J D Rowley

    Haematology and Blood Transfusion
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Nonrandom chromosome changes in human cancers may offer a growth advantage to cancer cells by altering genes involved in nucleic acid biosynthesis. This advantage likely varies based on individual genetic makeup.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    No chromosome arm unturned: in memory of Roland Berger 1934-2012.

    Leukemia·2014
    Same author

    Broadband terahertz pulse emission from ZnGeP2.

    Optics letters·2012
    Same author

    Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.

    Cancer genetics and cytogenetics·2002
    Same author

    Chromosome translocations: dangerous liaisons revisited.

    Nature reviews. Cancer·2002
    Same author

    The pattern of gene expression in human CD34(+) stem/progenitor cells.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    The pattern of gene expression in mouse Gr-1(+) myeloid progenitor cells.

    Genomics·2001
    Same journal

    Transferrin derivatives with growth factor activities in acute myeloblastic leukemia: an autocrine/paracrine pathway.

    Haematology and blood transfusion·1990
    Same journal

    Dependence of serum erythropoietin level on erythropoiesis in leukemia.

    Haematology and blood transfusion·1990
    Same journal

    Determination of soluble interleukin-2 receptors after bone marrow transplantation.

    Haematology and blood transfusion·1990
    Same journal

    Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.

    Haematology and blood transfusion·1990
    Same journal

    Interleukin-1 production in childhood acute lymphoblastic leukemia during chemo- and radiotherapy according to BFM (Berlin-Frankfurt-Münster) protocol.

    Haematology and blood transfusion·1990
    Same journal

    Complications of bone marrow transplantation in Chinese.

    Haematology and blood transfusion·1990
    See all related articles

    Area of Science:

    • Genetics
    • Oncology
    • Molecular Biology

    Background:

    • Nonrandom chromosome changes are consistently observed in human malignancies.
    • The precise significance of these chromosomal aberrations remains largely unknown.
    • A potential role involves conferring a proliferative advantage to cancer cells.

    Purpose of the Study:

    • To explore the hypothesis that chromosome alterations provide a proliferative advantage in cancer.
    • To investigate the link between chromosome aberrations, nucleic acid biosynthesis genes, and cancer cell proliferation.
    • To consider how patient genetic background might influence the effect of chromosome aberrations.

    Main Methods:

    • Analysis of nonrandom chromosome changes in human malignancies.
    • Investigating gene alterations related to nucleic acid biosynthesis.

    Related Experiment Videos

  • Comparative analysis of proliferative advantages conferred by different chromosome aberrations.
  • Correlating aberration effects with patient genetic constitutions.

    • Main Results:

    • Chromosome aberrations in cancer are not random events.
    • Alterations in nucleic acid biosynthesis genes due to chromosome changes may enhance cell proliferation.
    • The extent of proliferative advantage varies, potentially influenced by individual genetic factors.

    Conclusions:

    • Chromosome aberrations likely play a functional role in cancer development by promoting cell proliferation.
    • Targeting nucleic acid biosynthesis pathways affected by chromosomal alterations could be a therapeutic strategy.
    • Personalized approaches considering patient genetics are crucial for understanding and treating cancer.